Big pharmaceutical companies could face increased competition from generic drugmakers under two proposals put forth by the Obama administration on Monday despite earlier savings extracted from drugmakers as part of last year's healthcare law.
President Barack Obama, as part of his 2012 budget proposal, called for cutting the number of years drugmakers could exclusively market brand-name biologic drugs to 7 years from 12.
He also set his sights on ending controversial "pay-for-delay" deals that affect traditional, chemical drugs by giving the U.S. Federal Trade Commission power to block them. Under such pacts, brand-name and generic drugmakers settle patent challenges with payoffs that delay lower-cost rivals from reaching the market.
The proposals face a tough challenge of getting through the divided Congress, but could alter the landscape for consumers' access to cheaper medicines.
They quickly drew industry protests.
--
Any questions, please drop me a line.
******************************************************
Follow us on:
What's New:
http://www.nursefriendly.com/new/
Blogger:
http://4nursing.blogspot.com/
Facebook:
http://www.nursefriendly.com/facebook
Linked In:
http://www.linkedin.com/in/nursefriendly
Nursing Entrepreneurs, Nurses In Business
http://nursingentrepreneurs.ning.com/
Twitter!
http://www.nursefriendly.com/twitter
StumbleUpon,
http://www.nursefriendly.com/stumbleupon
******************************************************
Sincerely,
Andrew Lopez, RN
Nursefriendly, Inc. A New Jersey Corporation.
38 Tattersall Drive, Mantua New Jersey 08051
http://www.nursefriendly.com info@nursefriendly.com ICQ #6116137
856-415-9617, (fax) 415-9618
150,000 + Nurse-Reviewed & Approved Nursing Links
http://www.4nursing.com
http://www.legalnursingconsultant.com
http://www.nursinghumor.com
http://www.nursefriendly.com
http://www.nursingcasestudy.com
http://www.nursingentrepreneurs.com
http://www.nursingexperts.com
No comments:
Post a Comment